review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0399-8320(05)82128-1 |
P698 | PubMed publication ID | 15980750 |
P2093 | author name string | Eveline Boucher | |
Florence Trivin | |||
Jean-Luc Raoul | |||
Claudia Lefeuvre | |||
Elisabeth Le Prise | |||
P2860 | cites work | Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus | Q77655399 |
Combined radiochemotherapy for postoperative recurrence of oesophageal cancer | Q34408399 | ||
Relapse patterns after chemo-radiation for carcinoma of the oesophagus. | Q35151818 | ||
The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction | Q36644282 | ||
Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer | Q36648325 | ||
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival | Q39405901 | ||
Radiation therapy for loco-regionally recurrent esophageal cancer after surgery | Q39413262 | ||
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer | Q39436075 | ||
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group | Q42557591 | ||
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy | Q43515558 | ||
Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus | Q43988072 | ||
Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial | Q44017893 | ||
Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer | Q44028630 | ||
Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma | Q44383143 | ||
Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer | Q44434920 | ||
Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. | Q44691624 | ||
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study | Q71975350 | ||
Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease | Q73169047 | ||
EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer | Q73600851 | ||
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer | Q73707393 | ||
Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy | Q75401601 | ||
Prognosis of patients with advanced carcinoma of the esophagus with complete response to chemotherapy and/or radiation therapy: a questionnaire survey in Japan | Q77164632 | ||
The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer | Q77424619 | ||
P433 | issue | 5 | |
P921 | main subject | esophageal carcinoma | Q18553999 |
P304 | page(s) | 557-560 | |
P577 | publication date | 2005-05-01 | |
P1433 | published in | Gastroenterologie Clinique et Biologique | Q15756157 |
P1476 | title | [Palliative treatment of esophageal carcinoma: chemotherapy and palliative care] | |
P478 | volume | 29 |
Search more.